FDA Clinical Site Inspections Should Look At Recruitment Tactics - IG Report
This article was originally published in The Tan Sheet
FDA clinical site inspections should focus on recruitment tactics as well as data integrity, the HHS Office of the Inspector General suggests in a report on clinical trial recruitment released June 12.
You may also be interested in...
The commercial pressures to hasten clinical trial enrollment could be ripe for legislative attention in the context of consideration of bills to improve IRBs.
The HHS Inspector General's Office study of clinical trial recruitment practices will include a review of academic and industry clinical trial ads.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC